AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
Impact of apolipoprotein(a) on in vitro angiogenesis
Authors: Schulter, V Koolwijk, P Peters, E Frank, S Hrzenjak, A Graier, WF van Hinsbergh, VWM Kostner, GM
Citation: V. Schulter et al., Impact of apolipoprotein(a) on in vitro angiogenesis, ART THROM V, 21(3), 2001, pp. 433-438
Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo
Authors: Frank, S Gauster, M Strauss, J Hrzenjak, A Kostner, GM
Citation: S. Frank et al., Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo, GENE THER, 8(6), 2001, pp. 425-430
Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities
Authors: Schmidt, R Schmidt, H Fazekas, F Launer, LJ Niederkorn, K Kapeller, P Lechner, A Kostner, GM
Citation: R. Schmidt et al., Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities, HYPERTENSIO, 38(1), 2001, pp. 110-115
Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage - Results of the Austrian Stroke Prevention Study
Authors: Schmidt, H Fazekas, F Kostner, GM van Duijn, CM Schmidt, R
Citation: H. Schmidt et al., Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage - Results of the Austrian Stroke Prevention Study, STROKE, 32(2), 2001, pp. 405-412
Adenovirus-mediated rescue of lipoprotein lipase-deficient mice - Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice
Authors: Strauss, JG Frank, S Kratky, D Hammerle, G Hrzenjak, A Knipping, G von Eckardstein, A Kostner, GM Zechner, R
Citation: Jg. Strauss et al., Adenovirus-mediated rescue of lipoprotein lipase-deficient mice - Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice, J BIOL CHEM, 276(39), 2001, pp. 36083-36090
A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect
Authors: deCampo, A Schallmoser, K Schmidt, H Toplak, H Kostner, GM
Citation: A. Decampo et al., A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect, ATHEROSCLER, 157(2), 2001, pp. 524-525
Role of various tissues in apo(a) fragmentation and excretion of fragmentsby the kidney
Authors: Frank, S Hrzenjak, A Blaschitz, A Dohr, G Kostner, GM
Citation: S. Frank et al., Role of various tissues in apo(a) fragmentation and excretion of fragmentsby the kidney, EUR J CL IN, 31(6), 2001, pp. 504-512
Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages
Authors: Zimmermann, R Panzenbock, U Wintersperger, A Levak-Frank, S Graier, W Glatter, O Fritz, G Kostner, GM Zechner, R
Citation: R. Zimmermann et al., Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages, DIABETES, 50(7), 2001, pp. 1643-1653
Urinary excretion of apolipoprotein(a): relation to other plasma proteins
Authors: Kostner, K Spitzauer, S Rumpold, H Maurer, G Knipping, G Hrzenjak, A Frank, S Kostner, GM
Citation: K. Kostner et al., Urinary excretion of apolipoprotein(a): relation to other plasma proteins, CLIN CHIM A, 304(1-2), 2001, pp. 29-37
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis
Authors: Caplice, NM Panetta, C Peterson, TE Kleppe, LS Mueske, CS Kostner, GM Broze, GJ Simari, RD
Citation: Nm. Caplice et al., Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis, BLOOD, 98(10), 2001, pp. 2980-2987
Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes
Authors: Buechler, C Ullrich, H Ritter, M Porsch-Oezcueruemez, M Lackner, KJ Barlage, S Friedrich, SO Kostner, GM Schmitz, G
Citation: C. Buechler et al., Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes, BLOOD, 97(4), 2001, pp. 981-986
Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes
Authors: Hammel, M Schwarzenbacher, R Gries, A Kostner, GM Laggner, P Prassl, R
Citation: M. Hammel et al., Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes, BIOCHEM, 40(47), 2001, pp. 14173-14181
Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth andinduces apoptosis in human MCF-7 and HBL-100 breast cancer cells
Authors: Pussinen, PJ Lindner, H Glatter, O Reicher, H Kostner, GM Wintersperger, A Malle, E Sattler, W
Citation: Pj. Pussinen et al., Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth andinduces apoptosis in human MCF-7 and HBL-100 breast cancer cells, BBA-MOL C B, 1485(2-3), 2000, pp. 129-144
Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins
Authors: Zimmermann, R Sartipy, P Winkler, R Zechner, R Hurt-Camejo, E Kostner, GM
Citation: R. Zimmermann et al., Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins, BBA-MOL C B, 1484(2-3), 2000, pp. 316-324
MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms - Three-year follow-up of the Austrian stroke prevention study
Authors: Schmidt, R Schmidt, H Fazekas, F Kapeller, P Roob, G Lechner, A Kostner, GM Hartung, HP
Citation: R. Schmidt et al., MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms - Three-year follow-up of the Austrian stroke prevention study, ART THROM V, 20(7), 2000, pp. 1811-1816
Genetic aspects of microangiopathy-related cerebral damage
Authors: Schmidt, H Fazekas, F Kostner, GM Schmidt, R
Citation: H. Schmidt et al., Genetic aspects of microangiopathy-related cerebral damage, J NEUR TR-S, (59), 2000, pp. 15-21
Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification andin vitro refolding
Authors: Hrzenjak, A Frank, S Maderegger, B Sterk, H Kostner, GM
Citation: A. Hrzenjak et al., Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification andin vitro refolding, PROTEIN ENG, 13(9), 2000, pp. 661-666
Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran
Authors: Meraji, S Abuja, PM Hayn, M Kostner, GM Morris, R Oraii, S Tatzber, F Wonisch, W Zechner, R Gey, KF
Citation: S. Meraji et al., Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran, ATHEROSCLER, 150(2), 2000, pp. 403-412
In human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca2+ distribution
Authors: Fleischhacker, E Esenabhalu, VE Holzmann, S Skrabal, F Koidl, B Kostner, GM Graier, WF
Citation: E. Fleischhacker et al., In human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca2+ distribution, ATHEROSCLER, 149(1), 2000, pp. 33-42
Familial hypercholesterolemia in Austria reflects the multi-ethnic origin of our country
Authors: Schmidt, H Kostner, GM
Citation: H. Schmidt et Gm. Kostner, Familial hypercholesterolemia in Austria reflects the multi-ethnic origin of our country, ATHEROSCLER, 148(2), 2000, pp. 431-432
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a).
Authors: Tate, JR Berg, K Couderc, R Dati, F Kostner, GM Marcovina, SM Rifai, N Sakurabayashi, I Steinmetz, A
Citation: Jr. Tate et al., International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a)., CLIN CH L M, 37(10), 1999, pp. 949-958
Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice
Authors: Frank, S Hrzenjak, A Kostner, K Sattler, W Kostner, GM
Citation: S. Frank et al., Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice, BBA-MOL C B, 1438(1), 1999, pp. 99-110
Evaluation of a newly discovered LDL-receptor-mutation (exon 10, GAC > AAC, D471N, "FH graz-1") in familial hypercholesterolemia - a family study
Authors: de Campo, A Toplak, H Wascher, TC Schallmoser, K Friehs, A Schmidt, H Kostner, GM
Citation: A. De Campo et al., Evaluation of a newly discovered LDL-receptor-mutation (exon 10, GAC > AAC, D471N, "FH graz-1") in familial hypercholesterolemia - a family study, ACT MED AUS, 26(1), 1999, pp. 20-25
Crystal structure of human beta 2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome
Authors: Schwarzenbacher, R Zeth, K Diederichs, K Gries, A Kostner, GM Laggner, P Prassl, R
Citation: R. Schwarzenbacher et al., Crystal structure of human beta 2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome, EMBO J, 18(22), 1999, pp. 6228-6239
Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction?
Authors: Graier, WF Posch, K Fleischhacker, E Wascher, TC Kostner, GM
Citation: Wf. Graier et al., Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction?, DIABET RE C, 45(2-3), 1999, pp. 153-160
Risultati: 1-25 | 26-33